Q32 Bio Inc.

US$9.25As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:QTTBHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (20.90%)
Div yield —
ROE 23.96%
Biotechnology
Beta (5Y) (0.11)
PE TTM 5.834
TSR TTM 229.18%
Mkt cap US$276.8M
ROIC 7.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
17.07%
(17.94%)
Hold 2|4|3|3|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.21
0.22
0.22
0.23
18.42%
19.00%
11.91%
23.22%
Revenue$M
23.93
24.56
23.88
23.26
10.02%
9.53%
2.19%
0.94%
Peers (US$276.8M)
Cap (US$)
PE
279.8M
—
Capital
TTM
5Y
10Y
Leveragex
0.671
0.092
0.056
EBIT/Intx
0.303
0.420
0.302
Own earn%
(9.13)
73.46
77.15
Sh yield%
17.06
39.20
39.82
Owners
Insiders/Inst%
13.10
34.62
Short interest%
5.82
SBC / revenue%
5.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
24–30
$1 testx
0.0
Incr. ROIC%
7